Norman Lisa R, Basso Michael
Public Health Program, Ponce School of Medicine, Ponce, PR 00732, USA.
Curr Drug Abuse Rev. 2015;8(1):50-71. doi: 10.2174/1874473708666150309124820.
Neuropyschological dysfunction, ranging from mild cerebral indicators to dementia has been a consistent part of the medical picture of HIV/AIDS. However, advances in medical supervision, particularly as a result of antiretroviral (ARV) treatment, have resulted in some mitigation of the neuropsychological effects of HIV and necessitate re-evaluation of the pattern and nature of HIV-related cognitive or mental deficits. The associated enhancements in morbidity and mortality that have occurred as a result of ARV medication have led to a need for interventions and programs that maintain behaviors that are healthy and stop the resurgence of the risk of HIV transmission. Risk factors such as mental illness and substance use that may have contributed to the initial infection with HIV still need consideration. These risk factors may also increase neuropsychological dysfunction and impact observance of prevention for treatment and recommendations. Explicitly, a better comprehension of the role of substance use on the progression of HIV-related mental decline can enlighten management and evaluation of persons living with HIV with concurrent disorders of substance use. This review provides a summary of the neurophyschology of substance use and HIV and the existing research that has looked at the effects of both substance use and HIV disease on neurophyscological function and suggestions for future research and treatment.
神经心理功能障碍,从轻微的脑功能指标异常到痴呆,一直是艾滋病毒/艾滋病医学状况的一个持续存在的部分。然而,医疗监管的进步,特别是抗逆转录病毒(ARV)治疗的结果,已使艾滋病毒的神经心理影响有所减轻,因此有必要重新评估与艾滋病毒相关的认知或精神缺陷的模式和性质。抗逆转录病毒药物治疗导致的发病率和死亡率的相关改善,使得需要开展干预措施和项目,以维持健康行为并阻止艾滋病毒传播风险的再度出现。诸如精神疾病和药物使用等可能导致最初感染艾滋病毒的风险因素仍需加以考虑。这些风险因素也可能增加神经心理功能障碍,并影响对治疗预防措施的遵守和建议的执行。具体而言,更好地理解药物使用在与艾滋病毒相关的精神衰退进展中的作用,能够为同时患有药物使用障碍的艾滋病毒感染者的管理和评估提供启示。本综述总结了药物使用和艾滋病毒的神经心理学,以及现有研究中关于药物使用和艾滋病毒疾病对神经心理功能的影响,并提出了未来研究和治疗的建议。